A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD

Renton, Alan E., Majounie, Elisa, Waite, Adrian, Simón-Sánchez, Javier, Rollinson, Sara, Gibbs, J. Raphael, Schymick, Jennifer C., Laaksovirta, Hannu +68 more·2011·Neuron
DOI 10.1016/j.neuron.2011.09.010

Cited by (1,041)

Items 601–700 of 1,041

  1. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations
    Julie S. Snowden, Jennifer Adams, Jennifer Harris, J. C. Thompson, Sara J. Rollinson, Anna M. T. Richardson, Matthew S. Jones, D. Neary, David M. A. Mann, Stuart M. Pickering-Brown · 2015 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  2. Role of mitochondria in mutant SOD1 linked amyotrophic lateral sclerosis
    Wenzhi Tan, Piera Pasinelli, Davide Trotti · 2014 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  3. Neuropsychiatric changes precede classic motor symptoms in ALS and do not affect survival
    Eneida Mioshi, Jashelle Caga, Patricia Lillo, Sharpley Hsieh, Eleanor Ramsey, Emma M. Devenney, Michael Hornberger, John R. Hodges, Matthew C. Kiernan · 2013 · Neurology
  4. What we know about TMEM106B in neurodegeneration
    Alexandra M. Nicholson, Rosa Rademakers · 2016 · Acta Neuropathologica
  5. Novel antibodies reveal presynaptic localization of C9orf72 protein and reduced protein levels in C9orf72 mutation carriers
    P. Frick, C. Sellier, I. Mackenzie, Chieh-Yu Cheng, Julie Tahraoui-Bories, C. Martinat, R. Pasterkamp, J. Prudlo, D. Edbauer, M. Oulad-Abdelghani et al. · 2018 · Acta Neuropathologica Communications
  6. Molecular analysis and biochemical classification of TDP-43 proteinopathy
    Hiroshi Tsuji, Tetsuaki Arai, Fuyuki Kametani, Takashi Nonaka, Makiko Yamashita, Masami Masuda‐Suzukake, Masato Hosokawa, Mari Yoshida, Hiroyuki Hatsuta, Masaki Takao et al. · 2012 · Brain
  7. Cerebellar c9RAN proteins associate with clinical and neuropathological characteristics of C9ORF72 repeat expansion carriers
    Gendron, Tania F., van Blitterswijk, Marka, Bieniek, Kevin F., Daughrity, Lillian M., Jiang, Jie, Rush, Beth K., Pedraza, Otto, Lucas, John A., Murray, Melissa E., Desaro, Pamela et al. · 2015 · Acta Neuropathologica
  8. C9ORF72 Repeat Expansions in the Frontotemporal Dementias Spectrum of Diseases: A Flow-chart for Genetic Testing
    Isabelle Le Ber, Agnès Camuzat, Léna Guillot‐Noël, Didier Hannequin, Lucette Lacomblez, Véronique Golfier, Michèle Puel, Olivier Martinaud, Vincent Deramecourt, Sophie Rivaud-Péchoux et al. · 2013 · Journal of Alzheimer s Disease
  9. Translational potential of astrocytes in brain disorders
    Alexei Verkhratsky, Luca Steardo, Vladimir Parpura, Vedrana Montana · 2015 · Progress in Neurobiology
  10. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis
    Lucas T. Vu, Robert P. Bowser · 2016 · Neurotherapeutics
  11. Stress granules at the intersection of autophagy and ALS
    Zachary T. Monahan, Frank P. Shewmaker, Udai Bhan Pandey · 2016 · Brain Research
  12. Cellular Regulation of Amyloid Formation in Aging and Disease
    Esther Stroo, Mandy Koopman, Ellen A. A. Nollen, Alejandro Mata‐Cabana · 2017 · Frontiers in Neuroscience
  13. Immunotherapies for Neurodegenerative Diseases
    Ibrahim Mortada, Raymond Farah, Sanaa M. Nabha, David M. Ojcius, Youssef Fares, Wassim Youssef Almawi, Najwane Said Sadier · 2021 · Frontiers in Neurology
  14. SOD1 Aggregation and ALS: Role of Metallation States and Disulfide Status
    Yuewei Sheng, Madhuri Chattopadhyay, Julian P. Whitelegge, Joan Selverstone Valentine · 2013 · Current Topics in Medicinal Chemistry
  15. Antisense drugs make sense for neurological diseases
    Bennett, C. Frank, Kordasiewicz, Holly B., Cleveland, Don W. · 2021 · Annual Review of Pharmacology and Toxicology
  16. Molecular classification of amyotrophic lateral sclerosis by unsupervised clustering of gene expression in motor cortex
    Eleonora Aronica, Frank Baas, Anand M. Iyer, Anneloor L.M.A. ten Asbroek, Giovanna Morello, Sebastiano Cavallaro · 2014 · Neurobiology of Disease
  17. Role of FET proteins in neurodegenerative disorders
    Francesca Svetoni, Paola Frisone, Maria Paola Paronetto · 2016 · RNA Biology
  18. Risk factors and emerging therapies in amyotrophic lateral sclerosis
    Nowicka, Natalia, Juranek, Jakub, Juranek, Judyta K., Wojtkiewicz, Joanna · 2019 · International Journal of Molecular Sciences
  19. Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
    Sandra O. Tomé, Rik R. Vandenberghe, Simona Ospitalieri, Evelien Van Schoor, Thomas Tousseyn, Markus Otto, Christine A. F. Von Arnim, Dietmar Rudolf Thal · 2020 · Acta Neuropathologica Communications
  20. Neuropathology and emerging biomarkers in corticobasal syndrome
    Shunsuke Koga, Keith A. Josephs, Ikuko Aiba, Mari Yoshida, Dennis W. Dickson · 2022 · Journal of Neurology Neurosurgery & Psychiatry
  21. Focality, stochasticity and neuroanatomic propagation in ALS pathogenesis
    John Ravits · 2014 · Experimental Neurology
  22. The genetics of amyotrophic lateral sclerosis: current insights
    Janine Kirby, Afnan Al Sultan, Rachel Waller, Paul Roy Heath · 2016 · Degenerative Neurological and Neuromuscular Disease
  23. Axonal transport defects are a common phenotype in Drosophila models of ALS
    Katie R. Baldwin, Vinay K. Godena, Victoria L. Hewitt, Alexander J. Whitworth · 2016 · Human Molecular Genetics
  24. Depression in amyotrophic lateral sclerosis
    Elin Röös, Daniela Mariosa, Caroline Ingre, Cecilia Lundholm, Karin Wirdefeldt, Per M. Roos, Fang Fang · 2016 · Neurology
  25. TBK1 Mutation Spectrum in an Extended European Patient Cohort with Frontotemporal Dementia and Amyotrophic Lateral Sclerosis
    Julie van der Zee, Ilse Gijselinck, Sara Van Mossevelde, Federica Perrone, Lubina Dillen, Bavo Heeman, Veerle Bäumer, Sebastiaan Engelborghs, Jan De Bleecker, Jonathan Baets et al. · 2016 · Human Mutation
  26. Edaravone (Radicava): A Novel Neuroprotective Agent for the Treatment of Amyotrophic Lateral Sclerosis.
    Martin Paspe Cruz · 2018 · PubMed Central
  27. Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease
    Andrea Cortese, Janel E. Wilcox, James M. Polke, Roy Poh, Mariola Skorupinska, Alexander Martin Rossor, Matilde Laurá, Pedro José Tomaselli, Henry Houlden, Michael E. Shy et al. · 2019 · Neurology
  28. The role of the immune system in neurodegenerative disorders: Adaptive or maladaptive?
    Doty, Kevin R., Guillot-Sestier, Marie-Victoire, Town, Terrence · 2015 · Brain Research
  29. Iron and Neurodegeneration: Is Ferritinophagy the Link?
    Giorgio Biasiotto, Diego Di Lorenzo, Silvana Archetti, Isabella Zanella · 2015 · Molecular Neurobiology
  30. The distinct genetic pattern of ALS in Turkey and novel mutations
    Aslıhan Özoğuz, Özgün Uyan, Güneş Birdal, Ceren Tunca, Ece Kartal, Suna Lahut, Özgür Ömür, Zeynep Sena Ağım, Aslı Gündoğdu Eken, Nesli-Ece Şen et al. · 2015 · Neurobiology of Aging
  31. The Role of RNA in Biological Phase Separations
    Marta M. Fay, Paul Anderson · 2018 · Journal of Molecular Biology
  32. Newest Methods for Detecting Structural Variations
    Wouter De Coster, Christine Van Broeckhoven · 2019 · Trends in biotechnology
  33. Antibody Therapy Targeting RAN Proteins Rescues C9 ALS/FTD Phenotypes in C9orf72 Mouse Model
    Lien Nguyen, Fabio Montrasio, Amrutha Pattamatta, Solaleh Khoramian Tusi, Olgert Bardhi, Kevin D. Meyer, Lindsey R. Hayes, Katsuya Nakamura, Mónica Báñez-Coronel, Alyssa N. Coyne et al. · 2019 · Neuron
  34. The genetics of amyotrophic lateral sclerosis
    Melissa Nijs, Philip Van Damme · 2024 · Current Opinion in Neurology
  35. Preferential PPAR-α activation reduces neuroinflammation, and blocks neurodegenerationin vivo
    Mohammad Ali Esmaeili, Shilpi Yadav, Ravi Kr. Gupta, Garrett R. Waggoner, Abigail DeLoach, Noel Ylagan Calingasan, M. Flint Beal, Mahmoud Kiaei · 2015 · Human Molecular Genetics
  36. Disease Mechanisms ofC9ORF72Repeat Expansions
    Tania F. Gendron, Leonard Petrucelli · 2017 · Cold Spring Harbor Perspectives in Medicine
  37. Mechanisms of disease in frontotemporal lobar degeneration: gain of function versus loss of function effects
    Glenda Margaret Halliday, Eileen H. Bigio, Nigel J. Cairns, Manuela Neumann, Ian R. Mackenzie, David M. A. Mann · 2012 · Acta Neuropathologica
  38. A fruitful endeavor: Modeling ALS in the fruit fly
    Ian Casci, Udai Bhan Pandey · 2014 · Brain Research
  39. RAN translation—What makes it run?
    Katelyn M. Green, Alexander E. Linsalata, Peter K. Todd · 2016 · Brain Research
  40. Cortical synaptic and dendritic spine abnormalities in a presymptomatic TDP-43 model of amyotrophic lateral sclerosis
    Matthew Joseph Fogarty, Paul M. Klenowski, John D. Lee, Joy R. Drieberg-Thompson, Selena E. Bartlett, Shyuan Thieu Ngo, Massimo A. Hilliard, Mark C. Bellingham, Peter G. Noakes · 2016 · Scientific Reports
  41. Ageing as a risk factor for ALS/FTD
    Teresa Niccoli, Linda Partridge, Adrian M. Isaacs · 2017 · Human Molecular Genetics
  42. Poly-GR dipeptide repeat polymers correlate with neurodegeneration and Clinicopathological subtypes in C9ORF72-related brain disease
    Nobutaka Sakae, Kevin F. Bieniek, Yong‐Jie Zhang, Kelly Ross, Tania F. Gendron, Melissa Erin Murray, Rosa Rademakers, Leonard Petrucelli, Dennis W. Dickson · 2018 · Acta Neuropathologica Communications
  43. Amyotrophic lateral sclerosis
    Albert Christian Ludolph, Johannes Brettschneider, Jochen Hans Weishaupt · 2012 · Current Opinion in Neurology
  44. Non-canonical DNA structures: Diversity and disease association
    Aparna Bansal, Shikha Kaushik, Shrikant Kukreti · 2022 · Frontiers in Genetics
  45. The effect of music and multimodal stimulation on responses of premature infants in neonatal intensive care.
    Jayne M. Standley · 1998 · PubMed
  46. C9orf72 Hexanucleotide Repeat Expansions in Clinical Alzheimer Disease
    Harms, Matthew, Benitez, Bruno A., Cairns, Nigel, Cooper, Breanna, Cooper, Paul, Mayo, Kevin, Carrell, David, Faber, Kelley, Williamson, Jennifer, Bird, Tom et al. · 2013 · JAMA Neurology
  47. C9ORF72 Repeat Expansion in Amyotrophic Lateral Sclerosis in the Kii Peninsula of Japan
    Hiroyuki Ishiura, Yuji Takahashi, Jun Mitsui, Sohei Yoshida, Tameko Kihira, Yasumasa Kokubo, Shigeki Kuzuhara, Laura P.W. Ranum, Tomoko Tamaoki, Yaeko Ichikawa et al. · 2012 · Archives of Neurology
  48. Evidence that C9ORF72 Dipeptide Repeat Proteins Associate with U2 snRNP to Cause Mis-splicing in ALS/FTD Patients
    Shanye Yin, Rodrigo Lopez-Gonzalez, Ryan C. Kunz, Jaya Pal Gangopadhyay, Carl Borufka, Steven P. Gygi, Fen‐Biao Gao, Robin Reed · 2017 · Cell Reports
  49. Post-transcriptional Inhibition of Hsc70-4/HSPA8 Expression Leads to Synaptic Vesicle Cycling Defects in Multiple Models of ALS
    Alyssa N. Coyne, Ileana Lorenzini, Ching‐Chieh Chou, Meaghan Torvund, Robert S. Rogers, Alexander Starr, Benjamin L. Zaepfel, Jennifer Levy, Jeffrey Johannesmeyer, Jacob C. Schwartz et al. · 2017 · Cell Reports
  50. Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR
    Zongbing Hao, Liu Liu, Zhouteng Tao, Rui Wang, Haigang Ren, Hongyang Sun, Zixuan Lin, Zhixiong Zhang, Chenchen Mu, Jiawei Zhou et al. · 2019 · Nature Communications
  51. C9orf72 intermediate expansions of 24–30 repeats are associated with ALS
    Alzheimer’s Disease Neuroimaging Initiative, Iacoangeli, Alfredo, Al Khleifat, Ahmad, Jones, Ashley R., Sproviero, William, Shatunov, Aleksey, Opie-Martin, Sarah, Morrison, Karen E., Shaw, Pamela J., Shaw, Christopher E. et al. · 2019 · Acta Neuropathologica Communications
  52. RPS25 is required for efficient RAN translation of C9orf72 and other neurodegenerative disease-associated nucleotide repeats
    Shizuka B. Yamada, Tania F. Gendron, Teresa Niccoli, Naomi R. Genuth, Rosslyn Grosely, Yingxiao Shi, Idoia Glaria, Nicholas J. Kramer, Lisa Nakayama, Shirleen Fang et al. · 2019 · Nature Neuroscience
  53. Symptomatic treatments for amyotrophic lateral sclerosis/motor neuron disease
    Louisa Ng, Fary Khan, Carolyn Anne Young, Mary Pauline Galea · 2017 · Cochrane Database of Systematic Reviews
  54. Treatment of Frontotemporal Dementia
    Richard M. Tsai, A. Boxer · 2014 · Current Treatment Options in Neurology
  55. Psychological and Cognitive Markers of Behavioral Variant Frontotemporal Dementia–A Clinical Neuropsychologist's View on Diagnostic Criteria and Beyond
    Andreas Johnen, Maxime Bertoux · 2019 · Frontiers in Neurology
  56. Innate Immunity: A Common Denominator between Neurodegenerative and Neuropsychiatric Diseases
    F. Novellino, Valeria Sacca, A. Donato, P. Zaffino, M. Spadea, M. Vismara, B. Arcidiacono, N. Malara, I. Presta, G. Donato · 2020 · International Journal of Molecular Sciences
  57. Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation
    Elisa Giacomelli, Björn Friedhelm Vahsen, Elizabeth L. Calder, Yinyan Xu, Jakub Scaber, Elizabeth Gray, Ruxandra Dafinca, Kevin Talbot, Lorenz Studer · 2022 · Cell stem cell
  58. Pathogenic role of BECN1/Beclin 1 in the development of amyotrophic lateral sclerosis
    Nassif, Melissa, Valenzuela, Vicente, Rojas-Rivera, Diego, Vidal, René, Matus, Soledad, Castillo, Karen, Fuentealba, Yerko, Kroemer, Guido, Levine, Beth, Hetz, Claudio · 2014 · Autophagy
  59. Pathophysiological insights into ALS with C9ORF72 expansions
    Kelly L. Williams, Jennifer A. Fifita, Steve Vucic, Jennifer C. Durnall, Matthew C. Kiernan, Ian P. Blair, Garth A. Nicholson · 2013 · Journal of Neurology Neurosurgery & Psychiatry
  60. Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
    Christopher P Webster, Emma F. Smith, Pamela J. Shaw, Kurt J. De Vos · 2017 · Frontiers in Molecular Neuroscience
  61. A feedback loop between dipeptide-repeat protein, TDP-43 and karyopherin-α mediates C9orf72-related neurodegeneration
    Daniel A. Solomon, Alan Stepto, Wing Hei Au, Yoshitsugu Adachi, Danielle C. Diaper, Rachel Hall, Anjeet Rekhi, Adel Boudi, Paraskevi Tziortzouda, Youn‐Bok Lee et al. · 2018 · Brain
  62. Splicing repression is a major function of TDP-43 in motor neurons
    Aneesh Donde, Mingkuan Sun, Jonathan P. Ling, Kerstin E. Braunstein, Bo Pang, Xinrui Wen, Xueying Cheng, Liam Chen, Philip C. Wong · 2019 · Acta Neuropathologica
  63. Antisense Oligonucleotides for the Study and Treatment of ALS
    Benjamin D. Boros, Kathleen M. Schoch, Collin J. Kreple, Timothy M. Miller · 2022 · Neurotherapeutics
  64. Length of normal alleles of C9ORF72 GGGGCC repeat do not influence disease phenotype
    Nicola J. Rutherford, Michael G. Heckman, Mariely DeJesus‐Hernandez, Matt C. Baker, Alexandra I. Soto‐Ortolaza, Sruti Rayaprolu, Heather G. Stewart, Elizabeth C. Finger, Kathryn Volkening, William W. Seeley et al. · 2012 · Neurobiology of Aging
  65. Analysis of the<i>C</i><i>9orf72</i>Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide
    García-Redondo, Alberto, Dols-Icardo, Oriol, Rojas-García, Ricard, Esteban-Pérez, Jesús, Cordero-Vázquez, Pilar, Muñoz-Blanco, José Luis, Catalina, Irene, González-Muñoz, Miguel, Varona, Luis, Sarasola, Esther et al. · 2013 · Human Mutation
  66. Defects in optineurin- and myosin VI-mediated cellular trafficking in amyotrophic lateral sclerosis
    Vinod Sundaramoorthy, Adam K. Walker, Vanessa X. Tan, Jennifer A. Fifita, Emily P. McCann, Kelly L. Williams, Ian P. Blair, Gilles J. Guillemin, Manal A. Farg, Julie D. Atkin · 2015 · Human Molecular Genetics
  67. C9ORF72 Regulates Stress Granule Formation and Its Deficiency Impairs Stress Granule Assembly, Hypersensitizing Cells to Stress
    Niran Maharjan, Christina Künzli, Kilian Buthey, Smita Saxena · 2016 · Molecular Neurobiology
  68. Histone Methylation Regulation in Neurodegenerative Disorders
    Balapal S. Basavarajappa, Shivakumar Subbanna · 2021 · International Journal of Molecular Sciences
  69. Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy
    Marie‐Laure Caillet‐Boudin, Francisco-José Fernández-Gómez, Hélène Tran, Claire‐Marie Dhaenens, Luc Buée, Nicolas Sergeant · 2014 · Frontiers in Molecular Neuroscience
  70. Frontotemporal Lobar Degeneration: A Clinical Approach
    Elissaios Karageorgiou, Bruce L. Miller · 2014 · Seminars in Neurology
  71. The wobbler mouse, an ALS animal model
    Jakob Moser, Paolo Bigini, Thomas Schmitt‐John · 2013 · Molecular Genetics and Genomics
  72. Role of Oxidative Stress in the Pathogenesis of Amyotrophic Lateral Sclerosis: Antioxidant Metalloenzymes and Therapeutic Strategies
    Pavlína Hemerková, Martin Vališ · 2021 · Biomolecules
  73. Focusing on mitochondria in the brain: from biology to therapeutics
    Nanshan Song, Shuyuan Mei, Xiang-Xu Wang, Gang Hu, Ming Lu · 2024 · Translational Neurodegeneration
  74. Reactive oxygen species trigger motoneuron death in non-cell-autonomous models of ALS through activation of c-Abl signaling
    Fabiola Rojas, David González, Nicole Cortés, Estíbaliz Ampuero, Diego E. Hernández, Elsa Fritz, Sebastián Abarzúa, Alexis N. Martinez, Álvaro A. Elorza, Alejandra R. Alvarez et al. · 2015 · Frontiers in Cellular Neuroscience
  75. Mouse models of frontotemporal dementia
    Erik D. Roberson · 2012 · Annals of Neurology
  76. Serum microRNAs in patients with genetic amyotrophic lateral sclerosis and pre-manifest mutation carriers
    Axel Freischmidt, Kathrin Müller, Lisa Zondler, Patrick Weydt, Alexander Erich Volk, Anže Božič, Michael J. Walter, Michael von Bonin, Benjamin Mayer, Christine A. F. Von Arnim et al. · 2014 · Brain
  77. Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms
    Claudia Figueroa‐Romero, Junguk Hur, J. Simon Lunn, Ximena Paez-Colasante, Diane E. Bender, Raymond L. Yung, Stacey A. Sakowski, Eva L. Feldman · 2015 · Molecular and Cellular Neuroscience
  78. Ataxin-2 as potential disease modifier in C9ORF72 expansion carriers
    Marka van Blitterswijk, Bianca Mullen, Michael G. Heckman, Matthew Baker, Mariely DeJesus‐Hernandez, Patricia H. Brown, Melissa Erin Murray, Ging‐Yuek Robin Hsiung, Heather G. Stewart, Anna M. Karydas et al. · 2014 · Neurobiology of Aging
  79. Structural brain correlates of cognitive and behavioral impairment in MND
    Federica Agosta, Pilar M. Ferraro, Nilo Riva, Edoardo Gioele Spinelli, Adriano Chiò, Elisa Canu, Paola Valsasina, Christian Lunetta, Sandro Iannaccone, Massimiliano Copetti et al. · 2016 · Human Brain Mapping
  80. The small heat shock protein B8 (HSPB8) efficiently removes aggregating species of dipeptides produced in C9ORF72-related neurodegenerative diseases
    Riccardo Cristofani, V. Crippa, G. Vezzoli, P. Rusmini, M. Galbiati, M.E. Cicardi, M. Meroni, Veronica Ferrari, B. Tedesco, Margherita Piccolella et al. · 2017 · Cell Stress and Chaperones
  81. Psychiatric disorders in C9orf72 kindreds
    Emma M. Devenney, Rebekah M. Ahmed, Glenda Margaret Halliday, Olivier Piguet, Matthew C. Kiernan, John R. Hodges · 2018 · Neurology
  82. Gene Therapy for ALS—A Perspective
    M Cappella, Chiara Ciotti, Mathilde Cohen-Tannoudji, Maria Grazia Biferi · 2019 · International Journal of Molecular Sciences
  83. CGG repeat RNA G-quadruplexes interact with FMRpolyG to cause neuronal dysfunction in fragile X-related tremor/ataxia syndrome
    Sefan Asamitsu, Yasushi Yabuki, Susumu Ikenoshita, Kosuke Kawakubo, Moe Kawasaki, Shingo Usuki, Yuji Nakayama, Kaori Adachi, Hiroyuki Kugoh, Kazuhiro Ishii et al. · 2021 · Science Advances
  84. Genetic analysis of amyotrophic lateral sclerosis identifies contributing pathways and cell types
    Sara Sáez-Atiénzar, Sara Bandrés‐Ciga, Rebekah G. Langston, Jonggeol Jeffrey Kim, Shing Wan Choi, Regina Hertfelder Reynolds, ITALSGEN, Yevgeniya A. Abramzon, Ramita Dewan, Sarah Ahmed et al. · 2021 · Science Advances
  85. Montreal Cognitive Assessment (MoCA): Validation study for Frontotemporal Dementia
    Sandra Freitas, Mário Rodrigues Simões, Lara Alves, Diana Duro, Isabel J. Santana · 2012 · Journal of Geriatric Psychiatry and Neurology
  86. Cerebellar Integrity in the Amyotrophic Lateral Sclerosis - Frontotemporal Dementia Continuum
    Rachel H. Tan, Emma M. Devenney, Carol Dobson‐Stone, John B. Kwok, John R. Hodges, Matthew C. Kiernan, Glenda Margaret Halliday, Michael Hornberger · 2014 · PLoS ONE
  87. Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer's disease
    Irwin, David J., Trojanowski, John Q., Grossman, Murray · 2013 · Frontiers in Aging Neuroscience
  88. Tracking the progression of social cognition in neurodegenerative disorders
    Kumfor, Fiona, Irish, Muireann, Leyton, Cristian, Miller, Laurie, Lah, Suncica, Devenney, Emma, Hodges, John R, Piguet, Olivier · 2014 · Journal of Neurology, Neurosurgery &amp; Psychiatry
  89. Parkinsonian syndrome in familial frontotemporal dementia
    Siuda, Joanna, Fujioka, Shinsuke, Wszolek, Zbigniew K. · 2014 · Parkinsonism &amp; Related Disorders
  90. Pathogenesis/genetics of frontotemporal dementia and how it relates to ALS
    Janis Bennion Callister, Stuart M. Pickering-Brown · 2014 · Experimental Neurology
  91. C9ORF72 hexanucleotide expansions of 20–22 repeats are associated with frontotemporal deterioration
    Estrella Gómez‐Tortosa, Jesús Gallego, Rosa Guerrero, Alberto Marcos, Eulogio Gil-Neciga, María José Sainz, Asunción Díaz, Emilio Franco Macías, María José Trujillo-Tiebas, Carmen Ayuso et al. · 2013 · Neurology
  92. Gray and white matter changes in presymptomatic genetic frontotemporal dementia: a longitudinal MRI study
    Jessica L. Panman, Lize Corrine Jiskoot, Mark J.R.J. Bouts, Lieke H. H. Meeter, Emma Louise van der Ende, Jackie M. Poos, Rogier A. Feis, Anneke J.A. Kievit, Rick van Minkelen, Elise G.P. Dopper et al. · 2019 · Neurobiology of Aging
  93. Fine tuning of the unfolded protein response by ISRIB improves neuronal survival in a model of amyotrophic lateral sclerosis
    Ricardo Bugallo, Elías Marlin, Ana Baltanás, Estefanía Toledo, Roberto Ferrero, Rodrigo Vinueza‐Gavilanes, Laura Larrea, Montserrat Arrasate, Tomás Aragón · 2020 · Cell Death and Disease
  94. Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting
    Azin Amin, Nirma D. Perera, Philip M. Beart, Bradley J. Turner, Fazel Shabanpoor · 2020 · Cells
  95. Nuclear pore complexes — a doorway to neural injury in neurodegeneration
    Coyne, Alyssa N., Rothstein, Jeffrey D. · 2022 · Nature Reviews Neurology
  96. Phase to Phase with TDP-43
    Yulong Sun, Avijit Chakrabartty · 2017 · Biochemistry
  97. Tau pathology in frontotemporal lobar degeneration with C9ORF72 hexanucleotide repeat expansion
    Kevin F. Bieniek, Melissa Erin Murray, Nicola J. Rutherford, Monica Castanedes‐Casey, Mariely DeJesus‐Hernandez, Amanda M. Liesinger, Matthew Baker, Khrista Boylan, Rosa Rademakers, Dennis W. Dickson · 2012 · Acta Neuropathologica
  98. Distinct Clinical Characteristics of C9orf72 Expansion Carriers Compared With GRN, MAPT, and Nonmutation Carriers in a Flanders-Belgian FTLD Cohort
    Tim Van Langenhove, Julie van der Zee, Ilse Gijselinck, Sebastiaan Engelborghs, Rik R. Vandenberghe, Mathieu Vandenbulcke, Jan De Bleecker, Anne Sieben, Jan J. Versijpt, Adrian Ivanoiu et al. · 2013 · JAMA Neurology
  99. Genetics insight into the amyotrophic lateral sclerosis/frontotemporal dementia spectrum
    Ai-Ling Ji, Xia Zhang, Weiwei Chen, Wenjuan Huang · 2017 · Journal of Medical Genetics
  100. Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms
    Andrea Markovinović, Raffaello Cimbro, Tereza Ljutić, Jasna Križ, Boris Rogelj, Ivana Munitić · 2017 · Progress in Neurobiology